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OBJECTIVEdThe prevalence of gestational diabetes mellitus (GDM) is rising. There is little
evidence to demonstrate the effectiveness of one dietary therapy over another. We aimed to
investigate the effect of a low–glycemic index (LGI) versus a conventional high-ﬁber diet on
pregnancy outcomes, neonatal anthropometry, and maternal metabolic proﬁle in GDM.
RESEARCHDESIGNANDMETHODSdNinety-nine women (age 26–42 years; mean6
SD prepregnancy BMI 24 6 5 kg/m2) diagnosed with GDM at 20–32 weeks’ gestation were
randomized to follow either an LGI (n = 50; target glycemic index [GI] ~50) or a high-ﬁber
moderate-GI diet (HF) (n = 49; target GI ~60). Dietary intake was assessed by 3-day food records.
Pregnancy outcomes were collected from medical records.
RESULTSdThe LGI group achieved a modestly lower GI than the HF group (mean 6 SEM
476 1 vs. 536 1; P, 0.001). At birth, there was no signiﬁcant difference in birth weight (LGI
3.36 0.1 kg vs. HF 3.36 0.1 kg; P = 0.619), birth weight centile (LGI 52.56 4.3 vs. HF 52.26
4.0; P = 0.969), prevalence of macrosomia (LGI 2.1% vs. HF 6.7%; P = 0.157), insulin treatment
(LGI 53% vs. HF 65%; P = 0.251), or adverse pregnancy outcomes.
CONCLUSIONSdIn intensively monitored women with GDM, an LGI diet and a conven-
tional HF diet produce similar pregnancy outcomes.
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Gestational diabetes mellitus (GDM)is commonly deﬁned as any degreeof glucose intolerance with onset or
ﬁrst recognition during pregnancy (1). In
developed nations, between 4 and 8% of
pregnant women are presently affected
(2–4), and the prevalence will rise dra-
matically if the guidelines of the new In-
ternational Association of Diabetes in
Pregnancy Study Groups (IADPSG) are
adopted (3). The main adverse outcome
of GDM is excessive fetal growth resulting
in higher risk of large-for-gestational-age
(LGA) infants (birth weight .90th cen-
tile). Higher birth weight has been linked
with childhood obesity (5), cardiovascular
disease (6), and diabetes (5) later in life.
In the medical management of GDM,
the primary goal is to maintain mater-
nal blood glucose concentrations, espe-
cially postprandial levels, within an
acceptable range (7). Interventions that
reduce postprandial glucose levels, includ-
ing dietary strategies such as carbohydrate
restriction, have been shown to be effective
in reducing LGA and later obesity in type 1
diabetic offspring (8).
Postprandial glycemia can be reduced
without carbohydrate restriction by slowing
down the rate of carbohydrate digestion and
absorption. Compared with moderate–
or high–glycemic index (GI) foods con-
taining similar amount of carbohydrates,
low-GI (LGI) foodshave beendemonstrated
to reduce postprandial glucose in healthy
individuals (9). The GI of various foods
has been shown to be the same inpregnancy
as in the nonpregnant state (10). An LGI
meal pattern may therefore represent an al-
ternative strategy for reducing postprandial
glycemia in GDMwithout restricting carbo-
hydrate (11).
The effect of an LGI eating pattern on
obstetric outcomes in GDM has been little
studied. Moses et al. (12) found that a sig-
niﬁcantly higher proportion of women in
the higher-GI group met the criteria to
commence insulin compared with women
in the LGI group. In addition, 47% of the
women in the high-GI group who met the
criteria for insulin commencement avoided
insulin by switching to an LGI diet. How-
ever, they found no signiﬁcant differences
in key fetal and obstetric outcomes.
To our knowledge, this study is the
ﬁrst randomized controlled trial to deter-
mine the efﬁcacy of an LGI diet versus a
conventional healthy diet on pregnancy
outcomes in GDM. Our hypothesis was
that an LGI diet would reduce birth weight
(primary end point), birth weight centile,
ponderal index, and the prevalence of LGA
infants.
RESEARCH DESIGN AND
METHODSdThis study was a two-arm
parallel randomized controlled trial based
at theDiabetes Antenatal Clinic of the Royal
Prince Alfred Hospital, Camperdown,
Australia. With the exception of the study
dietitian (J.C.Y.L.), who provided the
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dietary education, all study personnel
and participants were blinded to dietary
assignment.
Subject recruitment, randomization,
and stratiﬁcation
Women aged 18–45 years diagnosed with
GDM by a 75-g oral glucose tolerance test
at 20–32 weeks’ gestation, with an other-
wise healthy singleton pregnancy, were
eligible for the study. GDM diagnosis was
based on the modiﬁed Australasian Diabe-
tes in Pregnancy Society (ADIPS) criteria:
fasting blood glucose level (BGL) $5.5
mmol/L, 1-h BGL $10.0 mmol/L, or 2-h
BGL $8.0 mmol/L. Most women were
tested at 26–32weeks, but testing occurred
earlier in those at high risk. Women who
had special dietary requirements (including
vegetarianism/veganism), preexisting dia-
betes, or pregnancy achieved by assisted
reproduction and those who smoked or
consumed alcohol during pregnancy were
excluded. A total of 482 women were ap-
proached between September 2008 and
November 2010, of whom 99 met the in-
clusion criteria and agreed toparticipate. The
enrolled subjects were centrally randomized
to study diet by computer-generated ran-
domnumbers, stratiﬁed by BMI (BMI,30
vs. $30 kg/m2) and weeks of gestation
(,28 or $28 weeks). The allocation se-
quence was unpredictable and concealed
from the recruiter. Participants received
routine GDM care regardless of dietary as-
signment, including instructions tomonitor
BGL before breakfast and 1 h after meals.
The treating endocrinologist (T.P.M. or
N.P.) reviewed the subjects every 2–4
weeks prior to 36 weeks and then every
week until delivery. Insulin treatment was
commenced if the mean fasting BGL or 1-h
postprandial BGL in the preceding week
exceeded 5.2 and 7.5mmol/L, respectively.
Demographics and dietary
assessment
At enrollment, demographic information,
family history of diabetes, and ethnicity
were recorded. Subjectswere asked to recall
their prepregnancy weight, were weighed,
and were asked to complete a 3-day food
record (including 2 weekdays and 1 week-
end day) at baseline and again at 36–37
weeks’ gestation. A two-dimensional food
model booklet was provided to the subjects
to assist in portion size estimation. Last re-
cordedweight before deliverywas obtained
from the medical record.
Dietary interventions
Subjects were randomized to one of two
healthy diets of similar protein (15–25%),
fat (25–30%), and carbohydrate (40–45%)
contentdone with an LGI (target GI#50)
and the other with a high-ﬁber content
and moderate GI, similar to the Australian
population average (HF) (target GI ;60)
(13–15). Both study diets provided all
essential nutrients for pregnancy other
than iron and iodine, which were sup-
plemented as appropriate by the treating
endocrinologist. The baseline 3-day
food diary provided information on
baseline dietary composition and served
as the basis of individualized dietary
counseling. Sample menus and their nu-
tritional analyses are given in Supple-
mentary Table A1.
Subjects attended at least three face-
to-face visits with the study dietitian,
scheduled to coincide with regular ante-
natal visits. A 24-h recall of all food and
drink intake was conducted during each
session to assess compliance. In the case of
noncompliance, suitable alternative foods
were encouraged. Food sample baskets
containing key foods for the assigned diet
were provided to promote product recog-
nition and dietary adherence. The content
of the sample baskets is listed in Supple-
mentary Table A2.
Data collection
Subjects provided blood samples at base-
line and;36 weeks’ gestation. Pregnancy
outcomes, including birth weight, infant
length, infant head circumference, and
the need for emergency caesarean section,
were obtained from the electronic medi-
cal records system. Gestational age was
based on the last menstrual period and
early pregnancy ultrasound. Birth weight
centile was calculated using a macro pro-
gram for Microsoft Excel (available from
http://www.gestation.net) that adjusted
for ethnic differences (16). The calculated
birth weight centile was used to categorize
the infant as small for gestational age
(birth weight ,10th centile), normal, or
LGA (birth weight .90th centile). Pon-
deral index, an estimate of neonatal adi-
posity, was calculated as birth weight in
kg 3 infant length (m)23. Macrosomia
was deﬁned as birth weight .4 kg.
Nutritional analysis and
assessment of compliance
The study dietitian entered the food
records into Australian nutrition analysis
software based on AUSNUT2001 (Food-
Works Professional 2009; Xyris Software,
Brisbane, Australia). The GI of individual
food items was assigned according to a
published method (17). Dietary glycemic
load (GL)was calculated as follows:∑GI3
available carbohydrate of each food in a
day/100. Dietary GI was calculated as fol-
lows: (dietary GL/total daily available car-
bohydrate)3 100. Subjects were deemed
compliant if their ﬁnal dietary GI was#50
in the LGI group and .50 in the HF
group.
Power calculation
Based on previous data, the study was
designed to provide 80% statistical power
to detect an ;260 g difference in birth
weight, with 60 subjects in each group.
Recruitment was halted at 99 subjects be-
cause the SD in birth weight among the
study population was smaller than ex-
pected. In theprimary analysis, the observed
SD of 416 g in birth weight provided 80%
power to detect a group difference of 246 g
in birth weight or an ;17% point differ-
ence in birth weight centile.
Statistical analyses
A biostatistician blinded to the diet allo-
cation performed the statistical analyses.
The primary analysis included all women
randomized who attended at least one
dietary education session but excluded
those with preterm delivery (,37 weeks;
n = 4; two from each group) regardless of
compliance. All statistical analyses were
performed with SPSS (version 19; IBM
Australia, St. Leonards, Australia). Results
for continuous data are reported as
mean 6 SD or mean 6 SEM, and cate-
gorical data (e.g., need for insulin) are re-
ported as percentage. Pearson x2 test was
used to test for differences between groups
for categorical data, and continuous data
were tested using one-way ANOVA. A
paired t test was used to assess within-
group changes from baseline to ﬁnal out-
comes.
The study was conducted according
to the guidelines laid down in the Decla-
ration of Helsinki, and all procedures
involving human subjects/patients were
approved by the Human Research Ethics
Committee of the Sydney South West
Area Health Service (Royal Prince Alfred
Hospital Zone). Informed consent was
obtained from all subjects in this study.
RESULTSdThe ﬂow of subjects
through the study is shown in Sup-
plementary Fig. 1. Of the 99 subjects
recruited, four delivered prematurely
(,37 weeks) and three withdrew before
the ﬁrst dietary instruction session, leaving
92 subjects in the primary analysis. Sub-
ject characteristics are shown in Table 1.
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At baseline, subjects in the LGI group had
signiﬁcantly higher 2-h postload blood
glucose levels (LGI 8.6 6 1.2 mmol/L vs.
HF 8.06 1.3mmol/L; P = 0.024) but were
otherwise similar to those in the HF
group. At baseline, both groups had a rel-
atively LGI diet (LGI 496 1 vs. HF 526 2)
(Table 2). At the end of the intervention
(36–37 weeks’ gestation), the diets were
matched for macro- and micronutrients,
but the LGI group had a signiﬁcantly
lower GI and GL than the HF group as
per protocol (both P, 0.001). Compared
with data at baseline, intake of fat, ﬁber,
calcium, iron, zinc, and folate signiﬁ-
cantly increased in subjects in the LGI
group. Subjects in the HF group had in-
creased energy intake and GL but not GI.
The results were similar in the secondary
analysis of “compliers” only except that
compliers in the LGI group (n = 30) had
signiﬁcantly decreased their GI, whereas
those in the HF group (n = 34) remained
unchanged from baseline (data not
shown).
At the end of the intervention, bio-
chemical parameters were similar be-
tween groups (Table 3). The results were
similar in the compliers-only analysis
(data not shown).In the primary analysis,
there were no signiﬁcant differences be-
tween groups in any of the pregnancy out-
comes (Table 4). Fewer women in the LGI
group gained an excessive amount of
weight according to the American Insti-
tute of Medicine guidelines (LGI 25% vs.
HF 42%; P = 0.095). Compliers in the LGI
group appeared to gain less weight than
those in the HF group (LGI 11.26 0.9 kg
vs. HF 13.7 6 1.0 kg; P = 0.073). There
was no signiﬁcant difference in fetal ab-
dominal circumference at 36–37 weeks’
gestation (mean6 SEM LGI 327.66 19.2
mm vs. HF 322.66 14.6 mm; P = 0.186).
Additional analyses with adjustments for
ethnicity (Asian vs. Caucasian), BMI; oral
glucose tolerance test results; baseline
characteristics including daily intakes
of energy, monounsaturated fatty acid,
polyunsaturated fatty acid, and sodium;
fasting BGL; fasting insulin; homeostasis
model assessment of insulin resistance;
and total cholesterol did not change the
lack of signiﬁcance of the between-group
comparisons.
CONCLUSIONSdContrary to our
hypothesis, this randomized controlled
trial of an LGI diet versus a conventional
high-ﬁber diet found no differences in key
pregnancy outcomes in GDM. Average
infant birth weight, birth weight centile,
and ponderal index were within healthy
norms in both groups. One explanation
for the ﬁndings is that both groups of
women achieved a relatively LGI diet, with
only a modest 5-point difference between
Table 1dSubject characteristics
LGI HF P*
n 47 45 d
Age (years) 34.0 6 4.1 32.4 6 4.5 0.062
Prepregnancy BMI (kg/m2) 23.9 6 4.4 24.1 6 5.7 0.837
Ethnicity (%)
Asian 59.6 55.6 0.697
Caucasian 31.9 40.0 0.419
Others 8.5 4.4 0.430
Week of gestation at diagnosis 26.1 6 4.0 26.0 6 4.3 0.951
Family history of type 2 diabetes (%)
Maternal 23.4 20.0 0.692
Paternal 21.3 33.3 0.194
Week of gestation at start of intervention 29.0 6 4.0 29.7 6 3.5 0.410
75-g OGTT results (mmol/L)
Fasting 4.6 6 0.5 4.7 6 0.7 0.279
1 h 9.4 6 1.4 9.7 6 1.6 0.501
2 h 8.6 6 1.2 8.0 6 1.3 0.024
Nulliparous (%) 61.7 64.4 0.785
Data are mean 6 SD except for ethnicity, family history of type 2 diabetes, and nulliparous, which are ex-
pressed as percentages. OGTT, oral glucose tolerance test. *P values calculated by one-way ANOVA for
continuous variables and Pearson x2 for categorical variables. P , 0.05 indicates statistical signiﬁcance.
Table 2dBaseline and end-of-intervention diet analysis
Baseline
P*
End of intervention
P*
P†
LGI HF LGI HF LGI HF
n 44 40 42 42
Energy (kJ) 7,240 6 240 6,630 6 260 0.089 7,680 6 260 8,090 6 300 0.307 0.141 ,0.001
Protein (g) 99.2 6 4.4 93.1 6 5.4 0.389 107.5 6 4.2 107.2 6 5.6 0.971 0.100 0.049
Total fat (g) 70.2 6 3.7 61.4 6 3.1 0.073 71.2 6 3.5 75.3 6 5.6 0.532 ,0.001 0.029
Saturated fat (g) 23.5 6 1.3 22.3 6 1.4 0.553 24.2 6 1.3 28.8 6 3.1 0.181 0.515 0.090
Monounsaturated fat (g) 27.0 6 1.7 22.4 6 1.3 0.035 27.4 6 1.6 26.8 6 1.7 0.797 0.887 0.034
Polyunsaturated fat (g) 12.6 6 0.9 10.1 6 0.7 0.032 13.5 6 0.8 12.5 6 1.3 0.488 0.465 0.065
Total available carbohydrate (g) 165.1 6 5.4 155.0 6 7.9 0.289 177.8 6 5.9 194.8 6 6.2 0.051 0.066 ,0.001
Sugars (g) 59.1 6 3.3 56.0 6 15.5 0.470 66.9 6 4.1 70.5 6 2.7 0.464 0.087 ,0.001
Starch (g) 105.0 6 3.5 99.6 6 8.1 0.523 111.1 6 4.1 124.6 6 5.6 0.056 0.190 0.001
Dietary ﬁber (g) 23 6 1 21 6 1 0.245 27 6 1 25 6 1 0.222 0.001 0.012
Calcium (mg) 887 6 54 915 6 41 0.680 1,080 6 62 1,030 6 43 0.507 0.005 0.013
GI 49 6 1 52 6 2 0.171 47 6 1 53 6 1 ,0.001 0.187 0.600
GL 81 6 3 84 6 6 0.598 84 6 3 105 6 4 ,0.001 0.453 0.001
Data are mean6 SEM. *P values calculated by one-way ANOVA to test for difference between groups. †P values calculated by paired sample t test to test for difference
compared with baseline.
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groups. Irrespective of dietary assignment,
all had received early nutrition counseling
in a group setting. Thus, on enrollment,
both groups were found to be consuming
a diet with a lower GI than population
norms. Compared with routine care in an-
other Australian study (18), both dietary
interventions resulted in a lower prevalence
of LGA (9 vs. 22%), macrosomia (4 vs.
21%), and emergency caesarean section
(16 vs. 20%). Hence, in the setting of in-
tensive medical management of GDM,
our ﬁndings suggest that both an LGI
and HF diet produce optimal pregnancy
outcomes.
Our ﬁndings increase the evidence
supporting the safety and efﬁcacy of an
LGI diet in GDM. Moses et al. (12) also
found no signiﬁcant differences in key
fetal and obstetric outcomes between sub-
jects who followed an LGI diet (GI = 48)
versus a higher-GI diet (GI = 56). How-
ever, unlike in the current study, they
found that a signiﬁcantly higher propor-
tion of women in the higher-GI group
met the criteria to commence insulin (59
vs. 29% in the LGI group). In addition,
almost one-half of the women in the
higher-GI group who met the criteria
for insulin commencement avoided insu-
lin by switching to an LGI diet. Their in-
sulin treatment protocol, however, was
different from that of the current study,
in whichmore stringent criteria were used
as the basis for insulin treatment.
A recent Canadian study (19), in
which women with GDM or impaired
glucose tolerance monitored their own
blood glucose levels, found that those
who were randomized to an LGI diet ver-
sus those assigned to the conventional
diet had a greater proportion of their
2-h postprandial levels on or below the
treatment target. Although there was a
tendency for higher birth weight in the
control group, the study was a pilot and
underpowered to detect a statistically sig-
niﬁcant difference.
Another explanation for our ﬁndings
is the relatively normal weight of most of
our subjects (68%had a BMI,25 kg/m2).
It is possible that an LGI diet may be more
effective among overweight and obese
gravidas with higher degrees of insulin re-
sistance and b-cell deﬁciency (20). Rhodes
et al. (21) reported higher head circumfer-
ence and a lower proportion of early deliv-
ery (,38 weeks’ gestation) in overweight
and obese nondiabetic pregnant women
assigned to a low GL diet. However, there
was no signiﬁcant difference in birth
weight, ponderal index, or pregnancy
weight gain, which are more sensitive to
maternal glycemic control (22).
The lack of difference in our study
may also relate to the timing and duration
of the intervention. Dietary instruction
began at the start of the third trimester (29
weeks’ gestation) and lasted, on average,
6–7 weeks. It is likely that maternal hy-
perglycemia during the ﬁrst and second
trimester will also drive excessive fetal
growth. In a post hoc analysis of women
who started dietary intervention before
25 weeks of gestation (10 from the LGI
group and 5 from the HF group), those in
the LGI group showed a tendency to
lower birth weight (LGI 3.2 6 0.2 kg vs.
HF 3.5 6 0.1 kg; P = 0.224) and lower
birth centile (LGI 45.3 6 11.0 vs. HF
57.5 6 12.2; P = 0.476), suggesting that
an earlier intervention may be beneﬁcial.
However, apart from a small number of
high-risk women who are screened early,
in most countries GDM screening occurs
Table 3dBiochemical parameters at baseline and end of intervention
Baseline
P*
End of intervention
P*
LGI HF LGI HF
n Mean 6 SEM n Mean 6 SEM n Mean 6 SEM n Mean 6 SEM
BGL (mmol/L) 44 4.7 6 0.1 42 4.6 6 0.1 0.665 42 4.3 6 0.1 32 4.4 6 0.1 0.464
Insulin (pmol/L) 44 73.1 6 9.4 42 70.5 6 5.3 0.813 40 83.8 6 16.1 30 73.0 6 5.2 0.525
HOMA2-IR (%) 44 1.3 6 0.2 42 1.3 6 0.1 0.780 38 1.2 6 0.1 39 1.3 6 0.1 0.670
Fructosamine (mmol/L) 43 202.3 6 2.5 41 199.9 6 2.3 0.479 41 196.3 6 2.3 40 193.7 6 2.2 0.412
HbA1c (%) 44 5.4 6 0.1 42 5.4 6 0.1 0.995 43 5.5 6 0.1 41 5.5 6 0.0 0.665
HOMA2-IR, homeostasis model assessment of insulin resistance. *P values calculated by one-way ANOVA to test for difference between groups.
Table 4dPregnancy outcomes by diet group
LGI HF
P*n Value n Value
Gestational age (weeks) 47 39.1 6 0.1 45 39.2 6 0.1 0.552
Birth weight (kg) 47 3.3 6 0.1 45 3.3 6 0.1 0.619
Birth weight centile 47 52.5 6 4.3 45 52.2 6 4.0 0.969
LGA (%) 47 12.8 45 4.4 0.157
Small for gestational age (%) 47 10.6 45 8.9 0.778
Macrosomia (%) 47 2.1 45 6.7 0.286
Infant head circumference (cm) 43 34.4 6 0.2 39 34.6 6 0.3 0.478
Infant length (cm) 47 49.7 6 0.3 45 49.7 6 0.3 0.995
Ponderal index (kg/m3) 47 27.2 6 0.3 45 27.0 6 0.4 0.614
Maternal weight gain (kg) 44 11.9 6 0.7 43 13.1 6 0.9 0.305
Below target (%)† 31.8 25.6 0.520
Within target (%)† 43.2 32.6 0.307
Above target (%)† 25.0 41.9 0.095
Insulin treatment (%) 47 53.2 45 65.1 0.251
Final daily insulin dose (units) 47 17.7 6 4.1 43 20.0 6 3.8 0.676
Emergency caesarean (%) 44 20.5 44 11.6 0.263
Data are mean 6 SEM or percent. *P values calculated by one-way ANOVA for continuous variables
and Pearson x2 for categorical variables. P , 0.05 indicates statistical signiﬁcance. †Based on Institute of
Medicine.Weight gain duringpregnancy: reexamining the guidelines [article online], 2009. Available fromhttp://
www.iom.edu/~/media/ﬁles/report%20ﬁles/2009/weight-gain-during-pregnancy-reexamining-the-guidelines/
report%20brief%20-%20weight%20gain%20during%20pregnancy.pdf.
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at 26–28 weeks’ gestation (23,24), which
means that any intervention in GDM will
be necessarily short. A more viable test
of our hypothesis would therefore be an
appropriately powered study in women
at high risk of developing GDM (e.g.,
women with a BMI .30 kg/m2 or previ-
ous GDM), starting on or before the
start of the second trimester, to deter-
mine the effect of an LGI diet on both
pregnancy outcome and risk of develop-
ing GDM.
The failure to achieve the target GI
of ;60 in the HF group could reﬂect
high recognition of the GI concept among
Australians diagnosed with diabetes, par-
ticularly among those with higher educa-
tion (in the current study, two of three
subjects had a university degree). In the
group education session conducted soon
after diagnosis, all the women, irrespec-
tive of future dietary assignment, were en-
couraged to limit total carbohydrate to
;180 g per day and to consume a greater
proportion as fruit and dairy productsd
changes which are likely to lower theGI of
the overall diet. Self-monitoring of blood
glucose levels was also encouraged and
may have provided feedback that discour-
aged consumption of high glycemic
foods. Finally, the use of data collected
from medical record may be subject to
inaccuracy, e.g., birth weights were mea-
sured and entered by different staff, there-
fore biasing the result toward the null
hypothesis.
In conclusion, we found that both an
LGI diet and a conventional high-ﬁber
diet produced comparable pregnancy
outcomes in women with GDM. Both
groups achieved a relatively low GI diet
and had mean birth weight, birth weight
centile, and pregnancy weight gain within
population norms. An LGI diet appears to
be a safe alternative to the traditional
pregnancy diet for women with GDM and
expands the range of dietary strategies
that can be offered. Further studies in
overweight and obese individuals and
earlier interventions in women with risk
factors for GDM are warranted.
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